Correct understanding of the status of targeted drugs in the treatment of pulmonary arterial hypertension
Xiong, C.-m.
Zhonghua Yi Xue Za Zhi 92(22): 1515-1516
2012
ISSN/ISBN: 0376-2491 PMID: 22944051 Document Number: 656877
Document emailed within 1 workday
Related Documents
Batyraliev, T.A.; Makhmutkhodzhaev, S.A.; Ekinsi, E.; Pataraia, S.A.; Pershukov, I.V.; Sidorenko, B.A.; Preobrazhenskiĭ, D.V. 2007: Pulmonary hypertension and right ventricular failure. Part XI. Endothelin receptor blockers in the treatment of primary pulmonary arterial hypertension Kardiologiia 47(7): 73-82Keir, G.John.; Walsh, S.L.F.; Gatzoulis, M.A.; Marino, P.S.; Dimopoulos, K.; Alonso, R.; Raposeiras-Roubin, S.; Renzoni, E.A.; Maher, T.M.; Wells, A.U.; Wort, S.John. 2014: Treatment of sarcoidosis-associated pulmonary hypertension: A single centre retrospective experience using targeted therapies Sarcoidosis Vasculitis and Diffuse Lung Diseases: Official Journal of Wasog 31(2): 82-90
Gupta, S. 1972: Role of pulmonary arterial-left atrial shunt in the treatment of pulmonary hypertension. Experimental study Journal of Thoracic and Cardiovascular Surgery 64(6): 949-952
Batyraliev, T.A.; Makhmutkhodzhaev, S.A.; Ekence, E.; Pataraia, S.A.; Pershukov, I.V.; Sidorenko, B.A.; Preobrezhenskiĭ, D.V. 2007: Pulmonary hypertension and right ventricular failure. Part VIII. Diagnosis, course, and prognosis of primary (idiopathic) pulmonary arterial hypertension Kardiologiia 47(3): 69-78
Negoiţă, C.I. 1972: Current status of diagnosis and treatment of arterial hypertension Medicina Interna 24(8): 899-911
Lador, F.éd.ér.; Beghetti, M.; Rochat, T. 2009: Early detection and treatment of pulmonary arterial hypertension Revue Medicale Suisse 5(226): 2317-2321
Budev, M.M.; Minai, O.A.; Arroliga, A.C. 2004: Overview of treprostinil sodium for the treatment of pulmonary arterial hypertension Drugs of Today 40(3): 225-234
2012: Current recommendations on diagnosis and treatment of pulmonary arterial hypertension Terapevticheskii Arkhiv 84(4): 57-63
Gorbunov, V.M.; Smirnova, G.F.; Andreeva, G.F.; Deev, A.D.; Shal'nova, S.A. 2009: Prevalence and predictors of masked inefficacy of treatment of arterial hypertension during use of various groups of antihypertensive drugs Kardiologiia 49(2): 32-37
Agapito, A.F.; Sousa, L.íd.; Oliveira, J.é A.; Feliciano, J.; Cacela, D.; Quininha, J. 2005: Eisenmenger syndrome in the adult--experience with new drugs for the treatment of pulmonary hypertension Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 24(3): 421-431
Oliván, J.; Miranda, M.J.; Chozas, J.; Gras, B.X.; Garrido, M. 1985: Long-term efficacy of captopril in the treatment of moderate/intensive arterial hypertension resistant to 3 antihypertensive drugs Medicina Clinica 85(14): 571-574
Nikitin, A.V.; Marks, S.I. 2014: The application of chromo- and laserotherapy for the treatment of the patients presenting with chronic obstructive pulmonary disease and concomitant arterial hypertension Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 4: 3-6
Usenko, G.A.; Usenko, A.G.; Vasendin, D.V. 2015: Features of oxygen utilization by the body of patients with arterial hypertension in the days of magnetic storms depending on the psychosomatic status and treatment options Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 101(1): 123-133
Kadyraliev, T.K. 1990: The morphological changes in the pulmonary resistive vessels in the development of high-altitude pulmonary arterial hypertension Arkhiv Patologii 52(2): 36-40
Fong Chee Yee; Singham, K.T. 1986: Pulmonary valve echocardiogram in the evaluation of pulmonary arterial hypertension in the presence of intracardiac shunts Medical Journal of Malaysia 41(3): 198-204
Meyer, P. 1983: Arterial hypertension, polyfactorial disease: attempt at understanding the interaction of inborn and acquired mechanisms Revue Medicale de la Suisse Romande 103(5): 427-431
Salgado-Escobar, J.L.; Ledesma-Velasco, M.; Munayer-Calderón, J.; Núñez-Garduño, D.; Salas-López, M.E.; Rodríguez-Hernández, L. 1987: Oxygen and tolazoline as vasodilators in pulmonary arterial hypertension secondary to high pulmonary blood flow Boletin Medico del Hospital Infantil de Mexico 44(3): 137-142
Steen, V.D.; Lucas, M.; Fertig, N.; Medsger, T.A. 2007: Pulmonary arterial hypertension and severe pulmonary fibrosis in systemic sclerosis patients with a nucleolar antibody Journal of Rheumatology 34(11): 2230-2235
Ahmadi-Simab, K.; Köhler, A.; Gross, W.L. 2007: Sustained success of therapy with inhaled iloprost for severe pulmonary arterial hypertension associated with systemic sclerosis and pulmonary fibrosis Clinical and Experimental Rheumatology 25(5): 760-762
De Meester, P.; Van De Bruaene, A.; Delcroix, M.; Belmans, A.; Herijgers, P.; Voigt, J-Uwe.; Budts, W. 2012: Pulmonary arterial pressure and right ventricular dilatation independently determine tricuspid valve insufficiency severity in pre-capillary pulmonary hypertension Journal of Heart Valve Disease 21(6): 743-748